Goldman Sachs
WHWK

Goldman Sachs’s Whitehawk Therapeutics WHWK Stock Holding History

Goldman Sachs’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196K Buy
+56,912
New +$178K ﹤0.01% 6092
2024
Q3 		– Sell
-154,270
Closed -$225K – 6131
2024
Q2 		$225K Buy
154,270
+104,691
+211% +$194K ﹤0.01% 5212
2024
Q1 		$116K Buy
+49,579
New +$95.6K ﹤0.01% 5222
2023
Q3 		– Sell
-25,215
Closed -$172K – 5912
2023
Q2 		$172K Buy
25,215
+519
+2% +$4.03K ﹤0.01% 5231
2023
Q1 		$179K Sell
24,696
-2,643
-10% -$28.2K ﹤0.01% 5337
2022
Q4 		$351K Buy
27,339
+1,563
+6% +$20.4K ﹤0.01% 5061
2022
Q3 		$364K Sell
25,776
-17,886
-41% -$235K ﹤0.01% 5184
2022
Q2 		$538K Sell
43,662
-15,885
-27% -$236K ﹤0.01% 5029
2022
Q1 		$1.01M Buy
+59,547
New +$1.14M ﹤0.01% 4806
2020
Q3 		– Sell
-1,960
Closed -$37K – 5571
2020
Q2 		$37K Buy
+1,960
New +$25.6K ﹤0.01% 5096
2020
Q1 		– Sell
-54,565
Closed -$510K – 5615
2019
Q4 		$510K Sell
54,565
-41,282
-43% -$344K ﹤0.01% 4495
2019
Q3 		$977K Sell
95,847
-7,097
-7% -$78.7K ﹤0.01% 4047
2019
Q2 		$1.41M Buy
+102,944
New +$1.56M ﹤0.01% 3768
2018
Q4 		– Sell
-7,230
Closed -$335K – 5752
2018
Q3 		$335K Buy
+7,230
New +$406K ﹤0.01% 4656

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Goldman Sachs's WHWK Position: Q1 2026 in Review

Goldman Sachs opened a new position in Whitehawk Therapeutics (WHWK) in Q1 2026: 56,912 shares worth $196K. The stake represents ﹤0.01% of the portfolio and ranks #6092 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in WHWK as recently as Q2 2024.

Goldman Sachs first reported a position in WHWK in Q3 2018 and has held it in 14 quarters since. The position peaked at $1.41M in Q2 2019. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Goldman Sachs held 56,912 shares of Whitehawk Therapeutics worth $196K as of Q1 2026.
  • Whitehawk Therapeutics was a new Goldman Sachs position in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6092 holding.
  • Goldman Sachs first reported a position in Whitehawk Therapeutics in Q3 2018 and has held it in 14 quarters since.
  • Goldman Sachs's Whitehawk Therapeutics position peaked at $1.41M in Q2 2019.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.